Inert, Robust Columns for Size Exclusion Chromatography
Agilent offers size exclusion chromatography (SEC) HPLC columns in a wide variety of pore sizes to address every aggregate or fragment analysis challenge. AdvanceBio SEC columns featuring unique hydrophilic bonding for minimal secondary interactions are available in 2.7 µm and 1.9 µm particle sizes, for high throughput, high resolution separations.
Agilent received two 2022 Scientists’ Choice Awards for Drug Discovery & Development, Virtual Event of the Year and Innovative Content of the Year, at the SLAS2022 International Conference & Exhibition on February 7th, 2022. The Scientists’ Choice Awards recognize the world’s most innovative and effective analytical science technologies and communications.
Professor Michael Butler, head of the National Institute for Bioprocessing Research and Training (NIBRT) Cell Technology Group (CTG), explains that the characterisation and analysis of glycans is important for the biopharma sector as it can help in the development of therapeutic agents, such as monoclonal antibodies and other recombinant proteins. These are used in therapies in a range of serious conditions including cancer, inflammatory diseases, and cardiovascular diseases. The mechanism of action depends upon their strong affinity to molecular targets associated with disease.